{
    "2020-12-30": [
        [
            {
                "time": "",
                "original_text": "智飞生物(300122)：15价肺炎疫苗正式进入临床III期 研发管线估值重塑持续进行",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "15价肺炎疫苗",
                        "临床III期",
                        "研发管线",
                        "估值重塑"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "增资扩股平风波，沃森生物押注三款新冠疫苗",
                "features": {
                    "keywords": [
                        "增资扩股",
                        "沃森生物",
                        "新冠疫苗",
                        "押注"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}